newsfilter
← Latest News
GlobeNewswire·

INmune Bio Advances Ebstrocel™ Toward Potential UK Approval in Mid-2027

Final pre-MAA package submitted to MHRA on October 20, 2026Full MAA submission targeted for early February 2027, under a revised strategy that could bring potential UK approval forward by approximately six weeksU.S. BLA